• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组多阶段恶性疟原虫疫苗对南美白狨猴疗效的初步观察

Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.

作者信息

Collins William E, Galland G Gale, Barnwell John W, Udhayakumar Venkatachalam, Sullivan JoAnn S, Nace Douglas, Tongren Jon Eric, Williams Tyrone, Roberts Jacquelin, Shi Ya Ping, Lal Altaf A

机构信息

Division of Parasitic Diseases, Centers for Disease Control and Prevention, Public Health Service, U. S. Department of Health and Human Services, Atlanta, Georgia 30341, USA.

出版信息

Am J Trop Med Hyg. 2005 Oct;73(4):686-93.

PMID:16222010
Abstract

A vaccine trial was conducted to determine the efficacy of a multicomponent candidate vaccine, FALVAC-1, against Plasmodium falciparum in Aotus nancymai monkeys. After two immunizations, animals were challenged intravenously with parasites of the Vietnam Oak Knoll (FVO) strain of P. falciparum. The primary outcome was to determine the protective response of the monkeys to immunization with the FALVAC-1 antigen produced in baculovirus when combined with different adjuvants (alum, QS-21, ASO2a, CRL1005/oil, and CRL1005/saline) as compared with FALVAC-1 with FCA/FIA and antigen alone. When compared with the monkeys immunized with FALVAC-1 alone, FALVAC-1 with FCA/FIA reduced the mean parasite count (to Day 11), reduced the mean accumulated parasitemia (through Day 11), and extended the number of days to treatment. None of the other 5 antigen-adjuvant combinations were able to provide discernable levels of protection based on log(parasitemia) and log(cumulative parasitemia) to Day 11.

摘要

进行了一项疫苗试验,以确定一种多组分候选疫苗FALVAC-1对南美白狨猴体内恶性疟原虫的疗效。两次免疫后,给动物静脉注射恶性疟原虫越南橡树岭(FVO)株的寄生虫。主要结果是确定与使用弗氏完全佐剂/不完全佐剂的FALVAC-1和单独抗原相比,当与不同佐剂(明矾、QS-21、ASO2a、CRL1005/油和CRL1005/盐水)联合使用时,用杆状病毒生产的FALVAC-1抗原免疫的猴子的保护反应。与单独用FALVAC-1免疫的猴子相比,使用弗氏完全佐剂/不完全佐剂的FALVAC-1降低了平均寄生虫计数(至第11天),降低了平均累积寄生虫血症(至第11天),并延长了至治疗的天数。基于第11天的对数(寄生虫血症)和对数(累积寄生虫血症),其他5种抗原-佐剂组合均无法提供可识别的保护水平。

相似文献

1
Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.重组多阶段恶性疟原虫疫苗对南美白狨猴疗效的初步观察
Am J Trop Med Hyg. 2005 Oct;73(4):686-93.
2
Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.重组恶性疟原虫裂殖子表面蛋白-1在夜猴体内的免疫原性及疗效
Mol Med. 1995 Mar;1(3):325-32.
3
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.对重组恶性疟原虫裂殖子表面蛋白1(MSP1)的免疫:绢毛猴体内的保护作用与抗MSP1抗体滴度及体外寄生虫抑制活性密切相关。
Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05.
4
Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys.含恶性疟原虫棒状体相关蛋白RAP1和RAP2的疫苗在玻利维亚松鼠猴中的效力
Am J Trop Med Hyg. 2000 Apr;62(4):466-79. doi: 10.4269/ajtmh.2000.62.466.
5
Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.用重组富含半胱氨酸的结构域间区域1α免疫夜猴可预防恶性疟原虫再次感染期间的严重疾病。
J Infect Dis. 2006 Mar 1;193(5):731-40. doi: 10.1086/500150. Epub 2006 Jan 30.
6
Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice.一种合成的恶性疟原虫MAP疟疾疫苗在夜猴和小鼠中的临床前评估。
Vaccine. 1999 Aug 20;18(1-2):89-99. doi: 10.1016/s0264-410x(99)00184-x.
7
Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.疟原虫裂殖子表面蛋白3与南美白狨猴对疟疾的抵抗力
J Infect Dis. 2002 Mar 1;185(5):657-64. doi: 10.1086/339187. Epub 2002 Feb 14.
8
Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.用代表恶性疟原虫75-kD裂殖子表面抗原部分的模型化合物对南美白狨猴进行免疫原性和疗效试验。
Am J Trop Med Hyg. 1992 Jun;46(6):691-707. doi: 10.4269/ajtmh.1992.46.691.
9
Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys.选择不同株恶性疟原虫用于在南美白狨猴中测试血液阶段疫苗。
Am J Trop Med Hyg. 1994 Aug;51(2):224-32. doi: 10.4269/ajtmh.1994.51.224.
10
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.通过恶性疟原虫EBA-175区域II DNA初免-蛋白加强免疫方案对夜猴进行保护。
J Infect Dis. 2001 Jan 15;183(2):303-312. doi: 10.1086/317933. Epub 2000 Dec 8.

引用本文的文献

1
Increased Parasitemia in Non-splenectomized Monkeys Treated with Clodronate Liposomes.氯膦酸脂质体治疗后非脾切除猴的寄生虫血症增加。
Front Cell Infect Microbiol. 2017 Sep 21;7:408. doi: 10.3389/fcimb.2017.00408. eCollection 2017.
2
Plasmodium vivax DBP binding to Aotus nancymaae erythrocytes is Duffy antigen dependent.间日疟原虫DBP与南美白狨红细胞的结合是达菲抗原依赖性的。
J Parasitol. 2010 Feb;96(1):225-7. doi: 10.1645/GE-2281.1.